Multicompartment Drug Monitoring Reveals Paired Brain−Liver Kinetics and Selective Central Nervous System Barrier Permeability in Rats
ACS Sensors · 22.05.2026 · 11 (5) · 3748-3762
DOI: 10.1021/acssensors.5c04463 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 22.04.2026. Verfasst von Yuchan Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Pharmacology & Therapeutics, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States. Hauptthemen laut MEDLINE: Liver, Brain, Blood-Brain Barrier, Drug Monitoring. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Characterizing drug distribution to target organs is of central importance to drug discovery, especially for compounds intended to reach the central nervous system (CNS). However, the current benchmark standard measurements, based on tissue homogenate, provide limited spatial and temporal resolution. Here, we use real-time electrochemical aptamer-based (E-AB) monitoring to determine drug concentrations across specific brain regions, blood, and liver of rats after intravenous dosing. Using vancomycin and tobramycin as models, we reveal significant regional differences in brain pharmacokinetics. Vancomycin shows distinct kinetics across cortex, hippocampus, and thalamus, crossing the blood-brain barrier (BBB) but showing limited transport across the blood-cerebrospinal fluid barrier (BCSFB). Tobramycin, despite its smaller size, fails to cross either barrier. Vancomycin's liver distribution is delayed and limited, resembling its brain kinetics more than blood. These findings challenge assumptions of uniform CNS drug distribution and fast liver uptake, highlighting the need for spatially and temporally resolved pharmacokinetic assessments. Our approach enables high-resolution, in vivo profiling of drug absorption, distribution, and clearance, offering a powerful tool to inform dosing strategies and improve translational outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Pharmacology & Therapeutics, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, United States.
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, United States.
- Bioanalytics, Ichor Life Sciences, Syracuse, New York 13203, United States.
ORCID-Profile: Karen Scida, Gregory V Carr, Netzahualcóyotl Arroyo-Currás
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Yuan, Y., Scida, K., Carr, G. V., Grohn, K., & Arroyo-Currás, N. (2026). Multicompartment Drug Monitoring Reveals Paired Brain−Liver Kinetics and Selective Central Nervous System Barrier Permeability in Rats. ACS Sensors, 11(5), 3748-3762. https://doi.org/10.1021/acssensors.5c04463
Vancouver
Yuan Y, Scida K, Carr GV, Grohn K, Arroyo-Currás N. Multicompartment Drug Monitoring Reveals Paired Brain−Liver Kinetics and Selective Central Nervous System Barrier Permeability in Rats. ACS Sensors. 2026;11(5):3748-3762. doi:10.1021/acssensors.5c04463
BibTeX
@article{Yuan2026,
author = {Yuan, Yuchan and Scida, Karen and Carr, Gregory V and Grohn, Kristopher and Arroyo-Currás, Netzahualcóyotl},
title = {Multicompartment Drug Monitoring Reveals Paired Brain−Liver Kinetics and Selective Central Nervous System Barrier Permeability in Rats},
journal = {ACS Sensors},
year = {2026},
volume = {11},
number = {5},
pages = {3748--3762},
doi = {10.1021/acssensors.5c04463}
}
EUVIMED